Bijoy K Menon
@bijoymenon
Followers
720
Following
945
Statuses
432
Stroke Physician, Trialist, Imager, Bumbling Parent, Student of Investing and Life
University of Calgary
Joined September 2009
RT @JohannaSeidenMD: BEST trial: In a Phase 2 trial, BXOS110, a novel PSD-95 protein inhibitor administered within 3 hours after stroke ons…
0
5
0
RT @StrokeAHA_ASA: As Dr Nerissa Ko mentioned, a stroke patient survivor reminded us why we do what we do. Dr William Mack with a grateful…
0
3
0
RT @AHAScience: The C3FIT trial was a protocol-driven multicenter cluster-randomized trial. Here is @ChaturvediNeuro’s perspective on the…
0
6
0
RT @GuidoFalconeMD: Very proud of this guy ... CONGRATULATIONS @CyprienRivier ! ! ! For receiving the Vascular Cognitive Impairment Awa…
0
7
0
RT @DrRamiMorsi: It was a great experience presenting our findings from the CEDAR study at #ISC25. #TakeMeBacktoLA
0
4
0
RT @Lance_Tran_: #ISC25 although the science is exciting, the best part of International Stroke Conference always is seeing the UAB fam aga…
0
3
0
Mostly co-pilot! Tagging the Schwamminator! @Braindoc_MGH @LaurenHSansing
@AHAScience @Braindoc_MGH @bijoymenon were other models used for summarization of talks at ISC? claude seems better than MS copilot for most use cases: e.g. summary of the ESCAPE-MeVO & DISTAL trials:
0
0
0
One cannot have asked for a better Chair than @LaurenHSansing! Me and the entire program committee have loved her leadership and how much she cares! Excited for #ISC2026 at New Orleans! @AHAScience
A huge thanks to all the #ISC25 attendees and program committee who made it such an incredible conference. And thanks to @bijoymenon for the partnership, and to all the @AHAScience and program meeting team members who made it all happen. See you all in New Orleans for #ISC26!
0
3
19
RT @Lance_Tran_: Dr Turc presenting at #ISC25 on thrombolytics in pts on DOACS, which in my understanding is more commonly than the states.…
0
3
0
RT @JohannaSeidenMD: LAMP Study: Despite early terminated study, among Chinese patients with acute minor ischemic stroke or high-risk TIA w…
0
6
0
RT @Lance_Tran_: #ISC25 Dr Pooja Khatri reviews IVT in non-disabling strokes/low NIH (~66% of strokes) 🏃♂️PRISMS & ARAMIS have inconsist…
0
5
0
RT @JohannaSeidenMD: ANGEL-TNK- in patients in China with acute LVO presenting 4.5-24 hrs, there was a significant benefit of IA TNK (mRS 0…
0
9
0
RT @VJNeurology: 🚨Findings from the DISTAL trial: endovascular thrombectomy plus BMT versus BMT alone. Listen to @FishingNeurons and @MPey…
0
9
0
RT @svinsociety: Mission Thrombectomy at #ISC2025! We had a powerful presence at the @American_Heart/@American_Stroke International Stroke…
0
11
0
RT @JohannaSeidenMD: PRESTIGE-AF results, as presented by Roland Veltkamp In ICH survivors with AF, DOAC use (2 weeks-1 year after ICH) pr…
0
13
0
RT @Lance_Tran_: @NguyenThanhMD presenting at #ISC25 on behalf of the DATE investigators results for dose escalation of adjunct TNK after s…
0
7
0
RT @amyyu_md: Moderating the Paola de Rango #Stroke in Women session with @tmadsenem was an #ISC25 highlight for me 💡@ChaturvediNeuro prese…
0
2
0
RT @StrokeAHA_ASA: Promising results to consider with post-thrombectomy thrombolytics in LVO pts as shown in PEARL and ANGEL-TNK results… I…
0
24
0